A list of downloadable documents created during development.
Deep vein thrombosis, pulmonary embolism (treatment, secondary prevention) - edoxaban tosylate [ID662]: equality impact assessment - guidance review
Deep vein thrombosis, pulmonary embolism (treatment, secondary prevention) - edoxaban tosylate [ID662]: final appraisal determination
Deep vein thrombosis, pulmonary embolism (treatment, secondary prevention) - edoxaban tosylate [ID662]: final scope
Deep vein thrombosis, pulmonary embolism (treatment, secondary prevention) - edoxaban tosylate [ID662]: final matrix
Deep vein thrombosis, pulmonary embolism (treatment, secondary prevention) - edoxaban tosylate [ID662]: NICE response to comments on the draft scope and provisional matrix
Deep vein thrombosis, pulmonary embolism (treatment, secondary prevention) - edoxaban tosylate [ID662]: equality impact assessment - scoping
Deep vein thrombosis, pulmonary embolism (treatment, secondary prevention) - edoxaban tosylate: draft scope for consultation (pre-referral) - March 2014
Deep vein thrombosis, pulmonary embolism (treatment, secondary prevention) - edoxaban tosylate: provisional matrix (pre-referral) - March 2014